Detalhe da pesquisa
1.
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody.
mBio
; 15(1): e0247723, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054729
2.
A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns.
Virus Res
; 341: 199308, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171391
3.
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.
Sci Transl Med
; 15(683): eabo2847, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36791207
4.
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice.
bioRxiv
; 2022 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35350201
5.
Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.
Microbiol Spectr
; 10(3): e0153822, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658571
6.
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Vaccine
; 40(26): 3621-3632, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577631
7.
Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial.
EClinicalMedicine
; 45: 101323, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35284808
8.
The Bone Marrow as Sanctuary for Plasma Cells and Memory T-Cells: Implications for Adaptive Immunity and Vaccinology.
Cells
; 10(6)2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34203839
9.
A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses.
Nat Commun
; 12(1): 6197, 2021 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707161
10.
Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial.
medRxiv
; 2021 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580673
11.
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate.
EBioMedicine
; 62: 103132, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33232870
12.
Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.
bioRxiv
; 2020 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32743571
13.
A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine.
Vaccines (Basel)
; 8(4)2020 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33348607
14.
A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine.
bioRxiv
; 2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766572